AZ1495 targets interleukin-1 receptor-associated kinases, which play a crucial role in the signaling pathways of immune response and inflammation. It targets CLK1, CLK2, CLK4, haspin, IRAK1, and IRAK4.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.